Isabelle Garcia-Lamrissi
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Single-cell multiplex approaches deeply map ON-target CRISPR-genotoxicity and reveal its mitigation by palbociclib and long-term engraftment.
Journal: Nature communications
Published: March 29, 2025
CRISPR editing to mimic porphyria combined with light: A new preclinical approach for prostate cancer.
Journal: Molecular therapy. Oncology
Published: October 03, 2023
Spleen route accelerates engraftment of human hematopoietic stem cells.
Journal: Biochemical and biophysical research communications
Published: June 08, 2021
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells.
Journal: Nature communications
Published: November 24, 2020
Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria).
Journal: Biochemical and biophysical research communications
Published: August 27, 2019
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
Journal: Nature communications
Published: August 28, 2018
Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.
Journal: Stem cells translational medicine
Published: April 20, 2016
Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells.
Journal: Leukemia
Published: January 05, 2016
Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin.
Journal: Experimental dermatology
Published: April 18, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026